Combo inhaler lacks evidence for first-line use in asthma: PBAC

The committee has revealed why it refused to fund budesonide-formoterol for mild asthma

Despite new international guidelines recommending combination budesonide-formoterol as first-line for mild asthma, the PBAC says there is a lack of evidence for such advice.